| | | Endpoints, Procedures, And Deviations Are On The Rise — Why? | Guest Column | A conversation with Jimmy Bechtel, MBA, Society for Clinical Research Sites (SCRS) and Ken Getz, MBA, Tufts Center for the Study of Drug Development (CSDD) | SCRS Chief Site Success Officer Jimmy Bechtel, MBA, and Tufts CSDD Executive Director Ken Getz, MBA, discuss why they're on the rise explore ways to address, and even accept, them. |
|
| | | Your Trial Is In Jeopardy. Time Is Critical. | Product | 20/20 Onsite | Expert ophthalmic teams rescue clinical trials with stabilized studies, nationwide coverage, and eye assessments, helping protect endpoints and regain timeline control quickly. |
|
| | | Takeda Keeps Patients The Focus Of PDTs For Rare Disease | Guest Column | A conversation with Kristina Allikmets, Takeda | Takeda’s Kristina Allikmets, MD, Ph.D, shares how her team incorporates patient voices and prioritizes innovations to reduce treatment burden, expand access, and develop plasma-derived therapies for rare diseases. |
|
| | | | | | CHOOSE YOUR OWN ADVENTURE |
|
| |
| You're receiving the Monday edition of the Clinical Leader newsletter, focusing on Clinical Sites, Patient Centricity, and Patient Recruitment. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
| | Connect With Clinical Leader: |
|
| |
|
|